40 related articles for article (PubMed ID: 11464286)
1. Cytokine signaling for proliferation, survival, and death in hematopoietic cells.
Miyajima A; Ito Y; Kinoshita T
Int J Hematol; 1999 Apr; 69(3):137-46. PubMed ID: 10222650
[TBL] [Abstract][Full Text] [Related]
2. Cyclin' on the viral path to destruction.
Hardwick JM
Nat Cell Biol; 2000 Nov; 2(11):E203-4. PubMed ID: 11056549
[No Abstract] [Full Text] [Related]
3. Cdks and cyclins link G1 length and differentiation of embryonic, neural and hematopoietic stem cells.
Lange C; Calegari F
Cell Cycle; 2010 May; 9(10):1893-900. PubMed ID: 20436288
[TBL] [Abstract][Full Text] [Related]
4. G1-CDK Activity Is Required for Both Proliferation and Viability of Myeloid/Erythroid Progenitors: A Critical Function of the v-Erba Oncoprotein.
Hofmann J; Sykora M; Beug H
ScientificWorldJournal; 2001; 1():99. PubMed ID: 30147579
[No Abstract] [Full Text] [Related]
5. Divide and differentiate: CDK/Cyclins and the art of development.
Ishidate T; Elewa A; Kim S; Mello CC; Shirayama M
Cell Cycle; 2014; 13(9):1384-91. PubMed ID: 24675894
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis and cell division.
O'Connor L; Huang DC; O'Reilly LA; Strasser A
Curr Opin Cell Biol; 2000 Apr; 12(2):257-63. PubMed ID: 10819542
[No Abstract] [Full Text] [Related]
7. The Ribosomal Protein RPLP0 Mediates PLAAT4-induced Cell Cycle Arrest and Cell Apoptosis.
Wang CH; Wang LK; Wu CC; Chen ML; Lee MC; Lin YY; Tsai FM
Cell Biochem Biophys; 2019 Sep; 77(3):253-260. PubMed ID: 31131438
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle and apoptosis.
Vermeulen K; Berneman ZN; Van Bockstaele DR
Cell Prolif; 2003 Jun; 36(3):165-75. PubMed ID: 12814432
[TBL] [Abstract][Full Text] [Related]
9. Cytokines as suppressors of apoptosis.
Lotem J; Sachs L
Apoptosis; 1999 Jun; 4(3):187-96. PubMed ID: 14634281
[TBL] [Abstract][Full Text] [Related]
10. Deciding when to exit.
Meserve JH; Duronio RJ
Elife; 2021 Feb; 10():. PubMed ID: 33576741
[TBL] [Abstract][Full Text] [Related]
11. The potential for chemical mixtures from the environment to enable the cancer hallmark of sustained proliferative signalling.
Engström W; Darbre P; Eriksson S; Gulliver L; Hultman T; Karamouzis MV; Klaunig JE; Mehta R; Moorwood K; Sanderson T; Sone H; Vadgama P; Wagemaker G; Ward A; Singh N; Al-Mulla F; Al-Temaimi R; Amedei A; Colacci AM; Vaccari M; Mondello C; Scovassi AI; Raju J; Hamid RA; Memeo L; Forte S; Roy R; Woodrick J; Salem HK; Ryan EP; Brown DG; Bisson WH
Carcinogenesis; 2015 Jun; 36 Suppl 1(Suppl 1):S38-60. PubMed ID: 26106143
[TBL] [Abstract][Full Text] [Related]
12. FoxO3a regulates erythroid differentiation and induces BTG1, an activator of protein arginine methyl transferase 1.
Bakker WJ; Blázquez-Domingo M; Kolbus A; Besooyen J; Steinlein P; Beug H; Coffer PJ; Löwenberg B; von Lindern M; van Dijk TB
J Cell Biol; 2004 Jan; 164(2):175-84. PubMed ID: 14734530
[TBL] [Abstract][Full Text] [Related]
13. G1-Cdk activity is required for both proliferation and viability of cytokine-dependent myeloid and erythroid cells.
Hofmann JF; Sykora M; Redemann N; Beug H
Oncogene; 2001 Jul; 20(31):4198-208. PubMed ID: 11464286
[TBL] [Abstract][Full Text] [Related]
14. [Changes in the activity of cyclin-kinase complexes governing cell transition from G1 phase to DNA replication phase in E1A + c-Ha-ras transformants transfected with the bcl-2 gene].
Neliudova AM; Aksenov ND; Pospelova TV
Tsitologiia; 2003; 45(2):149-57. PubMed ID: 12722479
[TBL] [Abstract][Full Text] [Related]
15. Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin.
Deep G; Singh RP; Agarwal C; Kroll DJ; Agarwal R
Oncogene; 2006 Feb; 25(7):1053-69. PubMed ID: 16205633
[TBL] [Abstract][Full Text] [Related]
16. Association of Bcl-2 with cyclin a/Cdk-2 complex and its effects on Cdk-2 activity.
Crescenzi E; Sannino M; Tonziello G; Palumbo G
Ann N Y Acad Sci; 2002 Nov; 973():268-71. PubMed ID: 12485875
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
